Related references
Note: Only part of the references are listed.Postoperative oligo-recurrence of non-small-cell lung cancer: clinical features and survival
Tomoyuki Hishida et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2016)
Role of Surgery in the Multimodal Treatment of Primary and Recurrent Leiomyosarcoma of the Inferior Vena Cava
Ferdinando Carlo Maria Cananzi et al.
JOURNAL OF SURGICAL ONCOLOGY (2016)
Post-Progression Survival after EGFR-TKI for Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutations
Yoshihito Kogure et al.
PLOS ONE (2015)
Prognostic Factors and the Significance of Treatment After Recurrence in Completely Resected Stage I Non-small Cell Lung Cancer
Yoshihisa Shimada et al.
CHEST (2013)
Risk Factors for Tumor Recurrence in Patients With Early-Stage (Stage I and II) Non-small Cell Lung Cancer Patient Selection Criteria for Adjuvant Chemotherapy According to the Seventh Edition TNM Classification
Ryo Maeda et al.
CHEST (2011)
Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non-Small-Cell Lung Cancer in Asia (IPASS)
Masahiro Fukuoka et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Health-Related Quality-of-Life in a Randomized Phase III First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients from Asia with Advanced NSCLC (IPASS)
Sumitra Thongprasert et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Surgical therapy for colorectal metastases to the liver
Timothy M. Pawlik et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2007)
Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection
Hiroshi Sugimura et al.
ANNALS OF THORACIC SURGERY (2007)
Predicting postrecurrence survival among completely resected nonsmall-cell lung cancer patients
BA Williams et al.
ANNALS OF THORACIC SURGERY (2006)
Surgical treatment of solitary adrenal metastasis from non-small cell lung cancer
O Mercier et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2005)
The in vitro effect of gefitinib ('Iressa') alone and in combination with cytotoxic chemotherapy on human solid tumours -: art. no. 83
LA Knight et al.
BMC CANCER (2004)
Long-term results of combined-modality therapy in resectable non-small-cell lung cancer
J Martin et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Prolonged survival after extracranial metastasectomy from synchronous resectable lung cancer
V Ambrogi et al.
ANNALS OF SURGICAL ONCOLOGY (2001)
Resection of adrenal metastases from non-small cell lung cancer: A multicenter study
H Porte et al.
ANNALS OF THORACIC SURGERY (2001)
Share Paper
